Desonide
Desonide is a low-potency topical corticosteroid used to treat skin inflammation and itching caused by conditions such as atopic dermatitis and other corticosteroid-responsive skin conditions.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 25 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Desonide: Patient Information Guide
A plain-language walkthrough of Desonide — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Desonide is a low-potency topical corticosteroid used to treat inflamed, itchy skin conditions. Here is the full range of supported uses across desonide products:
- Desonide Gel, 0.05% is indicated for mild to moderate atopic dermatitis (eczema) in patients 3 months of age and older
- Desonide cream, 0.05% and desonide ointment, 0.05% are indicated for the relief of inflammation and itching from corticosteroid-responsive dermatoses (skin conditions that respond to steroid treatment)
- Desonide cream and lotion (low to medium potency) are indicated for the relief of inflammation and itching from corticosteroid-responsive dermatoses
⚙️How it works▾
Desonide is a topical corticosteroid with anti-inflammatory, anti-itch, and blood vessel-narrowing (vasoconstrictive) properties. It is believed to work by prompting the body to produce proteins called lipocortins, which block the release of arachidonic acid — a building block for inflammation-causing chemicals like prostaglandins and leukotrienes. By reducing these chemicals at the skin level, desonide calms redness, swelling, and itch.
Desonide cream and ointment are considered to be in the low potency range compared to other topical corticosteroids, meaning they have a gentler effect — which also makes them suitable for sensitive skin and for use in young children when prescribed appropriately.
💊How it's taken▾
Desonide is applied directly to the skin as a thin layer. Frequency varies by product and condition severity:
- Desonide Gel: applied twice daily; treatment should not exceed 4 consecutive weeks
- Desonide cream or ointment: applied two to four times daily depending on severity; should not be used for longer than two weeks unless directed by a physician
- Desonide cream or lotion: applied two to three times daily depending on severity
Stop using it once your skin clears up, and contact your doctor if there is no improvement within the recommended timeframe. Never cover the treated area with tight, airtight dressings unless your doctor specifically instructs you to do so.
🤒Side effects — in detail▾
Most people tolerate desonide well, but some side effects can occur at the application site:
- Burning or stinging
- Skin rash
- Itching
- Dryness or irritation
- Folliculitis (inflamed hair follicles)
- Acne-like breakouts
- Skin lightening (hypopigmentation)
- Skin thinning or stretch marks with prolonged use
Some local reactions — such as stretch marks or skin thinning — can be permanent. If your skin worsens, becomes infected, or you develop an allergic reaction, stop using desonide and call your doctor.
⚠️Warnings & precautions▾
- HPA axis suppression: Desonide can be absorbed through the skin and interfere with the adrenal glands' normal function (HPA axis suppression). This is more likely with large treatment areas, prolonged use, or covered skin. Children are at higher risk because of their larger skin-to-body-mass ratio.
- Children: In addition to adrenal suppression, children using topical corticosteroids have shown slowed growth, delayed weight gain, and in rare cases, increased pressure in the skull (intracranial hypertension). Use only as directed and for as short a time as possible.
- Cushing's syndrome and high blood sugar: Significant absorption of topical corticosteroids can cause Cushing's syndrome (signs of too much cortisol) and may unmask latent diabetes mellitus (bring out hidden blood sugar problems).
- Skin infections: If a skin infection develops during treatment, appropriate antibiotic or antifungal treatment is needed. Desonide Gel should be stopped until the infection is controlled.
- Using multiple steroid products: Using more than one corticosteroid-containing product at the same time increases total steroid exposure and the risk of side effects.
🔀What it interacts with▾
The FDA label does not list specific drug-drug interactions for desonide, but there is one important consideration to be aware of:
- Other corticosteroid products: Using more than one product containing a corticosteroid (steroid) at the same time — including other topical steroids — increases the total amount of steroid absorbed into your body and raises the risk of side effects like adrenal suppression
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use desonide if you are allergic to any of its ingredients
- Tell your doctor if you are pregnant — desonide has shown potential to cause birth defects in animal studies, and it should only be used in pregnancy if the benefit clearly outweighs the risk
- Tell your doctor if you are breastfeeding — it is not known whether topically applied desonide passes into breast milk, so use with caution
- Desonide Gel is not recommended for infants younger than 3 months of age — safety and effectiveness have not been established in this age group
- Children are at greater risk of HPA axis suppression, Cushing's syndrome, growth retardation, and intracranial hypertension — monitor closely and use for the shortest time needed
- Tell your doctor if you have liver failure — this can increase how much desonide is absorbed through the skin
- Older adults should use with care; age-related changes in organ function and the use of other medications may affect how the drug works
🚑If you take too much▾
Although desonide is applied to the skin and not taken by mouth, too much can be absorbed into the body if used over large areas, for long periods, or under tight coverings. This can cause systemic (whole-body) effects similar to taking too much steroid internally — including adrenal gland suppression. If you suspect overuse or notice symptoms like unusual fatigue or weakness, contact your doctor.
📡Pharmacodynamics — effects in the body▾
In a clinical study of desonide gel, one out of 37 pediatric subjects (3%) who applied it twice daily for 4 weeks over at least 35% of their body surface area showed evidence of adrenal gland suppression based on a stimulation test. It was not known whether this suppression reversed after stopping the medication. This finding confirms that even a low-potency topical steroid like desonide can have measurable effects on the body's hormone system when used extensively.
🔬Pharmacokinetics — how your body processes it▾
How much desonide is absorbed through the skin depends on several factors — including the specific product formulation, the condition of the skin barrier, and whether the area is covered with an occlusive dressing. Inflamed or damaged skin allows more of the medication to pass through. Desonide cream and ointment are considered low-potency formulations, meaning less medication is absorbed compared to stronger topical steroids. Covering treated skin tightly for extended periods can significantly increase absorption.
📦How to store it▾
Store between 2° and 30°C (36° and 86°F).
📄 Written from Desonide’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Desonide — the kind of thing our pharmacy team would talk through with you at the counter.
What skin problems is desonide actually used for? ▾
How do I apply desonide correctly? ▾
How long can I use desonide? ▾
Is it safe to use desonide on my child? ▾
What side effects should I watch for? ▾
Can I use desonide if I am pregnant or breastfeeding? ▾
Is Desonide available over the counter? ▾
When was Desonide first available? ▾
Who makes Desonide? ▾
💬 Answers drafted from Desonide’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Desonide comes
Desonide is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
How this form is used
- Desonide cream and ointment are indicated for the relief of inflammation and itching caused by corticosteroid-responsive skin conditions
- Desonide cream and lotion are indicated as low to medium potency corticosteroids for inflammatory and itchy skin conditions
- Desonide cream or ointment: Apply a thin film to the affected area two to four times daily depending on severity
- Desonide cream: Do not use with occlusive dressings
- Desonide cream or ointment: Discontinue use once the condition is controlled
- Desonide cream or ointment: If no improvement after two weeks, contact your doctor for reassessment
Inhaler
How this form is used
- Verdeso (desonide gel) is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older
- Verdeso: Apply a thin layer to the affected area twice daily and rub in gently
- Verdeso: Do not use with occlusive dressings (airtight coverings)
- Verdeso: Avoid contact with eyes and mucous membranes
- Verdeso: Treatment beyond 4 consecutive weeks is not recommended
📊 Desonide across the U.S. market
How Desonide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (9) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Desonide is used
A general measure of how commonly Desonide is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Desonide is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Desonide prescribed? Of the 1,594 medications we measure, Desonide ranks #464 by Medicaid prescriptions — more than 71% of them.
Utilization by Desonide product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
desonide 0.5 MG/ML Topical Cream Most dispensed
Summed across the 12 of 29 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349351
desonide 0.0005 MG/MG Topical Ointment
Summed across the 10 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 204135
desonide 0.5 MG/ML Topical Lotion
Summed across the 6 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197572
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Desonide, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 28 of 70 listed Desonide NDCs with Medicaid activity.
🔍 Compare Desonide products
A representative set of FDA-listed product records for Desonide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| 0.5 mg/g | Topical | Almirall, LLC | NDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 0.5 mg/g | Topical | Actavis Pharma, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.5 mg/mL | Topical | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Advanced Rx of Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | View NDC → |
| 0.5 mg/g | Topical | Alembic Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Alembic Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Alembic Pharmaceuticals Inc. × 4 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 0.5 mg/g | Topical | Aleor Dermaceuticals Limited | ANDA | Find on DailyMed ↗ |
| 0.5 mg/mL | Topical | Aleor Dermaceuticals Limited | ANDA | Find on DailyMed ↗ |
| 0.5 mg/mL | Topical | Amneal Pharmaceuticals of New York LLC | ANDA | Find on DailyMed ↗ |
| 0.5 mg/g | Topical | Bayer HealthCare Pharmaceuticals Inc. | NDA | Find on DailyMed ↗ |
| 0.5 mg/g | Topical | Bryant Ranch Prepack × 7 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Cintex Services, LLC | ANDA | View NDC → |
| 0.5 mg/g | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.5 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Eckson Labs, LLC | ANDA | View NDC → |
| 0.03 g/60 g | Topical | Encore Dermatology Inc | NDA | View NDC → |
| 0.5 mg/g | Topical | Galderma Laboratories, L.P. | NDA | View NDC → |
| 0.5 mg/g | Topical | Galderma Laboratories, L.P. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Glenmark Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 1 kg/kg | — | Hubei Gedian Humanwell Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
| 0.5 mg/g | Topical | KMM Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.5 mg/g | Topical | LEO Pharma Inc. | NDA | Find on DailyMed ↗ |
| 0.5 mg/g | Topical | Northstar Rx Llc × 5 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd × 3 listings | NDA | View NDC → |
| 0.5 mg/g | Topical | Proficient Rx LP × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.5 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. × 4 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Teligent Pharma, Inc. | ANDA | Find on DailyMed ↗ |
| 0.5 mg/g | Topical | Unit Dose Services | ANDA | View NDC → |
| 0.5 mg/g | Topical | Viona Pharmaceuticals Inc × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Aarti Pharmalabs Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Farmabios S.p.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hubei Gedian Humanwell Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | MEDISCA Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Newchem Spa | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 100 kg/100 kg | — | Sicor S.r.l. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Symbiotec Pharmalab Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Symbiotica Speciality Ingredients Sdn.bhd | BULK INGREDIENT | View NDC → |
Showing 80 of 80 products — FDA National Drug Code Directory. See every product, package size and price: browse all 80 Desonide NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Desonide — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Desonide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Desonide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3254 6 dose forms · 6 strengths
-
Dose form (SCDF) Otic Solution RxCUI 654357No current FDA listingClinical drug / strength (SCD) 0.5 MG/MLRxCUI 654358 -
Dose form (SCDF) Topical Cream RxCUI 377668In current FDA listingsClinical drug / strength (SCD) 0.5 MG/MLRxCUI 349351 -
Dose form (SCDF) Topical Foam RxCUI 668349In current FDA listingsClinical drug / strength (SCD) 0.5 MG/MLRxCUI 668350 -
Dose form (SCDF) Topical Gel RxCUI 438864In current FDA listingsClinical drug / strength (SCD) 0.0005 MG/MGRxCUI 669081 -
Dose form (SCDF) Topical Lotion RxCUI 378605In current FDA listingsClinical drug / strength (SCD) 0.5 MG/MLRxCUI 197572 -
Dose form (SCDF) Topical Ointment RxCUI 378983In current FDA listingsClinical drug / strength (SCD) 0.0005 MG/MGRxCUI 204135
Look up RxCUI 3254 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Desonide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 14 more on the FDA NDC directory.
RxNorm drug class
Desonide belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 25 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Actavis Pharma, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.